Effects of alprostadil and ulinastatin on inflammatory response and lung injury after cardiopulmonary bypass in pediatric patients with congenital heart diseases

National Medical Journal of China

Volumn 88, Issue 41, 2008, Pages 2893-2897

  Jiang, Yi Fei ^a   Wang, Wen Wei ^a   Ye, Wen Lian ^a   Ni, Yu Fei ^a   Li, Jun ^a   Chen, Xiao Ling ^a   Jin, Sheng Wei ^a   Lian, Qing Quan ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Alprostadil; Anesthesia; Child; Extracorporeal circulation; Ulinastatin

Indexed keywords

CYTOKINE; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; PROSTAGLANDIN E1; TUMOR NECROSIS FACTOR ALPHA; ULINASTATIN; ANTIINFLAMMATORY AGENT; GLYCOPROTEIN;

ANESTHESIA INDUCTION; AORTA; AORTA CLAMPING; ARTERIAL BLOOD; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GAS ANALYSIS; BLOOD LEVEL; BLOOD SAMPLING; BREATHING; CARDIOPULMONARY BYPASS; CHILD; CLINICAL TRIAL; CONGENITAL HEART DISEASE; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; ELECTROCARDIOGRAM; HEART ATRIUM SEPTUM DEFECT; HEART RATE; HEART SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INFANT; INFLAMMATION; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTE ACTIVATION; LUNG INJURY; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; NEUTROPHIL; OXYGEN CONCENTRATION; OXYGEN SATURATION; OXYGENATION; PATIENT MONITORING; PRESCHOOL CHILD; RADIAL ARTERY; TREATMENT DURATION; ACUTE PHASE RESPONSE; CONGENITAL HEART MALFORMATION; FEMALE; MALE; RANDOMIZED CONTROLLED TRIAL;

ACUTE-PHASE REACTION; ALPROSTADIL; ANTI-INFLAMMATORY AGENTS; CARDIOPULMONARY BYPASS; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; GLYCOPROTEINS; HEART DEFECTS, CONGENITAL; HUMANS; LUNG INJURY; MALE; NEUTROPHILS;

EID: 77954826243     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Hsu LC. Current concepts on the adult respiratory distress syndrome. J Cardiothorac Vasc Anesth, 1997, 11:376-378.
2. Lespron Robles MC. Systemic inflammatory response in pediatric cardiac surgery. Arch Cardiol Mex, 2006, 76 Suppl 2:92-99.
3. Kawahara F, Kadoi Y. The effects of prostaglandin E1 on systemic and cerebral oxygenation before and during cardiopulmonary bypass. Chin Chem, 2002, 51:128-133. (Pubitemid 34195022)
4. Qiu W, Zheng L, Gu H, et al. Comparison between adult and infant lung injury in a rabbit ischemia-reperfusion model. J Thorac Cardiovasc Surg, 2008, 136:352-359.
5. Kapoor MC, Ramachandran TR, et al. Inflammatory response to cardiac surgery and strategies to overcome it. Ann Card Anaesth, 2004, 7:113-128.
6. Jarosfaw Panik, Jadwiga Moll, Agnieszka Cywińska-Bernas, et al. Proteolytic and cytokine balance abnormalities in children with congenital heart disease undergoing cardiac surgery with cardiopulmonary bypass. Kardiologia Polska, 2007, 65:1208-1214.
7. Hammer S, Fuchs AT, Ranker C, et al. Interleukin-6 and procalcitonin in scrum of children undergoing cardiac surgery with cardiopulmonary bypass. Acta Cardiol, 2004, 59:624-629. (Pubitemid 39619968)
8. Steinberg J, Fink G, Picone A, et al. Evidence of increased Matrix metalloproteinase-9 concentration in patients following cardiopulmonary bypass. J Extra Copor Techol, 2001, 33:218-222.
9. Joffs C, Gunasinghe HR, Multani MM, et al. Cardiopulmonary bypass induces the synthesis and release of matrix metalloproteinases. Ann Thorac Surg, 2001, 71:1518-1523. (Pubitemid 32452537)
10. Kawamura T, Nara N, Kadosake M, et al. Prostaglandin E1 reduces myocardial reperfusion injury by inhibiting proinflammatory cytokines production during cardiac surgery. Crit Care Med, 2000, 28:2201-2208. (Pubitemid 30604416)
11. Ng CS, Arifi AA, Wan S, et al. Ventilation during cardiopulmonary bypass: impact on cytokine response and cardiopulmonary function. Ann Thorac Surg, 2008, 85:154-162. (Pubitemid 350265814)
12. Giomarelli P, Scolletta S, Borrelli E, et al. Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10. Ann Thorac Surg, 2003, 76:117-123. (Pubitemid 36819726)